LEPTIN: BIOLOGICAL AND PATHOPHYSIOLOGICAL EFFECTS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper shows the most important biological effects of leptin, its role in the pathogenesis of insulin resistance and type 2 diabetes mellitus, and its effect on the development of cardiovascular diseases.

Full Text

Restricted Access

About the authors

A. Pashentseva

Email: a-pashentseva@yandex.ru
Candidate of Medical Sciences Samara State Medical University

A. Verbovoy

Professor MD Samara State Medical University

O. Kosareva

Candidate of Medical Sciences Samara State Medical University

References

  1. Yuan Т., Zhao W., et al. Association between four adipocins and insulin sensitivity in patients with obesity, type 1 or type 2 diabetes mellitus, and in the general Chinese population // Clin. Med. J. - 2010; 123 (15): 2018-22.
  2. Hirsch J., Frield S., Edens N. et al. The fat cell // Med. Clin. North. Amer. -1989; 73: 83-95.
  3. Friedman М., Halaas J. Leptin and the regulation of body weight in mammals // Nature. - 1998; 395 (6704): 763-70.
  4. Van Harmelen V., Reynisdottir S., Eriksson P. et al. Leptin secretion from subcutaneous and visceral adipose tissue in women // Diabetes. - 1998; 47: 913-7.
  5. Saad M., Riad-Gabriel M., KhunA. et al. Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity // J. Clin. Endocrin. Metab. - 1998; 83: 453-9.
  6. Vuagnat В., Pierroz D., Lalaoui M. et al. Evidence for a leptin- neuropeptide Y axis for the regulation of growth hormone secretion in the rat // Neuroendocrinology. - 1998; 67: 291-300.
  7. Halaas J., Gajiwala K., Maffey М. et al. Weight-reducing effects of the plasma protein encoded by the obese gene // Science. - 1995; 269: 543-6.
  8. Stephens T., Basinski М., Bristow P. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product // Nature. - 1995; 377: 530-2.
  9. Cusin I., Rohner-Jeanrenaud F., Stricker-Krongrad A. et al. The weight-reducing effect of an intracerebro-ventricular bolus injection of leptin in genetically obese fa/fa rats // Diabetes. - 1996; 45: 1446-50.
  10. Shigemura N., Ohta R., Kusakabe Y. et al. Leptin modulates behavioral responses to sweet substances by influencing peripheral taste structures // Endocrin. - 2004; 145: 839-47.
  11. De Luca C., Kowalski T., Zhang Y. et al. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes // J. Clin. Invest. - 2005; 115 (12): 3484-93.
  12. Mauro L., Catalano S., Bossi G. et al. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression // Cancer Res. - 2007; 67 (7): 3412-21.
  13. Spiegelman B., Flier J. Adipogenesis and obesity: rounding out the big picture // Cell. - 1996; 87: 377-89.
  14. Bjorbaek C., Kahn B. Leptin signaling in the central nervous system and the periphery // Recent Prog. Horm. Res. - 2004; 59: 305-31.
  15. Flier J. Obesity wars: molecular progress confronts an expanding epidemic // Cell. - 2004; 116: 337-50.
  16. Saad M., Khan A., Sharma A. et al. Physiological insulinemia acutely modulates plasma leptin // Diabetes. - 1998; 47: 544-9.
  17. Utriainen T., Malmstrom R., Makimattila S. et al. Supraphysiological hyperinsulinemia increases plasma leptin concentrations after 4 h in normal subjects // Diabetes. - 1996; 45: 1364-6.
  18. Saladin R., De Vos P., Guerre-Millo M. et al. Transient increase in obese gene expression after food intake or insulin administration // Nature. - 1995; 377: 527-9.
  19. D'Adamo M., Buongiomo E., Maroccia F. et al. Increased OB gene expression leads to elevated plasma leptin concentrations in patients with chronic primary hyperinsulinemia // Diabetes. - 1998; 47: 1625-9.
  20. Kieffer T., Habener J. The adipoinsular axis: effects of leptin on pancreatic b-cells // Am. J. Physiol. - 2000; 278: 1-14.
  21. Larsson H., Elmstahl S., Ahren B. Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women // Diabetes. - 1996; 45 (11): 1580-4.
  22. Haffner S., Miettinen K., Mykkanen I. et al. Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin / insulin ratio in non-diabetic subjects // Int. J. Obes. - 1998; 22: 899-905.
  23. Widjaja A., Stratton I., Horn R. et al. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects // J. Clin. Endocrinol. Metab. - 1997; 82 (2): 654-7.
  24. Muoio D., Dohm G., Tapscott E. et al. Leptin opposes insulin's effects on fatty acid partitioning in muscle isolated from obese ob ob mice // Am. J. Physiol. - 1999; 276: 913-21.
  25. Lord G., Matarese G., Howard J. Leptin modulates the T-cell immune response and reverses starvation- induced immunosuppression // Nature. - 1998; 394: 897-901
  26. Margetic S., Gazzola C., Pegg G. et al. Leptin: a review of its peripheral actions and interactions // Int. J. Obes. Relat. Metab. Disord. - 2002; 26: 407-1433.
  27. Cock T., Auwerx J. Leptin: cutting the fat off the bone // Lancet. - 2003; 362: 1572-4.
  28. Будылина М.В. Взаимоотношения лептина с физическим и половым развитием мальчиков в пубертатном периоде. Автореф. дис.. канд. мед. наук. Ижевск, 2005; 21 с.
  29. Кожевникова А.А. Взаимоотношения лептина с физическим и половым развитием девочек в пубертатном периоде. Автореф. дис.. канд. мед. наук. Казань, 2006; 23 с.
  30. Пашенцева A.B., Скудаева E.C., Вербовой А.Ф. Лептин, резистин и инсулинорезистентность у пациентов с сахарным диабетом 2 типа // Терапевт. - 2011; 5: 4-8.
  31. Вербовой А.Ф., Ворожцова Е.И., Орлова Т.Н. Метаболические показатели у мужчин с сахарным диабетом 2 типа и ишемической болезнью сердца // Фарматека. - 2012; 9: 60-4.
  32. Вербовой А.Ф., Соломонова Е.С., Пашенцева А.В. Лептин, резистин и оментин у пациентов с нарушенной толерантностью к глюкозе и сахарным диабетом 2 типа // Известия вузов. Поволжский регион. Медицинские науки. - 2012; 3: 52-7.
  33. Вербовой А.Ф., Вербовая Н.И., Капралова И.Ю. Адипонектин, лептин и другие метаболические показатели у больных гипотиреозом // Фарматека. -2014; 10: 67-9.
  34. Косарева О.В., Вербовой А.Ф., Шаронова Л.А. Оценка взаимосвязи адипокинов и параметров углеводного и жирового обменов у больных акромегалией // Эндокринология: новости, мнения обучение. - 2013; 1 (25): 54-7.
  35. Lembo G., Vecchione C., Fratta L. et al. Leptin induces direct vasodilation through distinct endothelial mechanisms // Diabetes. - 2000; 49 (2): 293-7.
  36. Hercule H., Schunck W., Gross V. et al. Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice // Arterioscler. Thromb. Vasa Biol. - 2009; 29 (1): 54-60.
  37. Fortuno A., Rodriguez A., Gomez-Ambrosi J. et al. Leptin inhibits angiotensin Il-induced intracellular calcium increase and vasoconstriction in the rat aorta // Endocrinology. - 2002; 143 (9): 3555-60.
  38. Фомина И.А. Взаимосвязь лептина и метаболических показателей при пубертатно-юношеском диспитуитаризме у юношей. Автореф. дис.. канд. мед. наук. Самара, 2009; 25 с.
  39. Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration // Diabetes. - 1999; 48 (4): 903-8.
  40. Shankar A., Xiao J. Positive relationship between plasma leptin level and hypertension // Hypertension. - 2010; 56 (4): 623-8.
  41. Korda M., Kubant R., Patton S. et al. Leptin-induced endothelial dysfunction in obesity // Am. J. Physiol. Heart Circ. Physiol. - 2008; 295: 1514-21.
  42. Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch- induced hypertrophy // J. Pharmacol. Exp. Ther. - 2005; 315: 1075-84.
  43. Loffreda S., Yang S., Lin H. et al. Leptin regulates proinflammatory immune responses // FASEB J. - 1998; 12: 57-65.
  44. Zeidan A., Purdham D., Rajapurohitam V. et al. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II - and endothelin-1-dependent mechanisms and mediates stretch-incluced hypertrophy // J. Pharmacol. Exp. Ther. - 2005; 315 (3): 1075-85.
  45. Karaduman M., Oktenli C. Musabak U. et al. Leptin, soluble interleikin-6 receptor, C - reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atheroscloretic plague // Clin. Exp. Immunol. - 2006; 143 (3): 452-7.
  46. Singh P., Hoffmann M., Wolk R. et al. Leptin induces C-reactive protein expression in vascular endothelial cells // Arterioscler. Thromb. Vasc. Biol. - 2007; 27 (9): 302-7.
  47. Singh P., Peterson Т., Barber K. et al. Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells // Biochem. Biophys. Res. Com. - 2010; 392 (1): 47-52.
  48. Sobel B., Taatjes D., Schneider D. Intramural plasminogen activator inhibitortype-1 and coronary atherosclerosis // Arterioscler. Thromb. Vasc. Biol. -2003; 23 (11): 1979-89.
  49. Волов Н.А., Адамов П.Б., Лебедева А.Ю. и др. Лептин - новый фактор риска сердечно-сосудистых заболеваний // Терапевт. - 2011; 8: 50-4.
  50. Sierra-Johnson J. et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United State population // Am. J. Cardiol. - 2007; 100: 234-9.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies